CARE Ratings Ltd
CARE Ratings Q3 FY26 earnings call: Revenue & Margins
Q3 FY26 investor presentation: what the company reported on revenue, margins and projects.
Based on CARE Ratings Ltd's Q3 FY26 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the presentation reports, not management guidance.
The short version
Q3 FY26 Standalone Revenue from Operations: Rs. Q3 FY26 Standalone: - EBITDA: Rs.
From CARE Ratings Ltd's Q3 FY26 earnings-call transcript · updated 25 Sept 2026.
Revenue & Sales Performance
- Q3 FY26 Standalone Revenue from Operations: Rs. 90.24 Crs, up 15% YoY (Page 12, 2)
- Q3 FY26 Consolidated Revenue from Operations: Rs. 112.12 Crs, up 16% YoY (Page 12, 2)
- Ratings Segment Revenue (9M FY26): Rs. 305.69 Crs, 17% growth YoY (Page 14, 10; Page 2, 2)
- Non-Ratings Segment Revenue (9M FY26): Rs. 36.71 Crs, 21% growth YoY (Page 14, 10; Page 2, 2)
2 more points management made on revenue & sales performance
Profitability & Margins
See what CARE Ratings Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
Top-ranked in Capital Markets
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what CARE Ratings Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points management made on order book & pipeline
CARE Ratings Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹131 Cr, net profit ₹53 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What CARE Ratings Ltd's management said in earlier quarters
- Q1 FY25 earnings call analysis →
- Q1 FY27 earnings call analysis →
- Q2 FY25 earnings call analysis →
- Q3 FY25 earnings call analysis →
- Q4 FY24 earnings call →
- Q4 FY23 earnings call →
- Q3 FY22 earnings call →
- Q2 FY22 earnings call →
- Q4 FY20 earnings call →
- Q2 FY20 earnings call →
- Q1 FY20 earnings call →
- Q4 FY19 earnings call →
Others in Capital Markets this season
- ICRA Ltd (Q3 FY26)
Q3 FY2026 revenue: ₹163.6 crore, up from ₹120.9 crore in Q3 FY2025 — a 35.3% year-on-year (YoY) increase (Page 7). Key concall takeaways from ICRA Ltd's Q3…
- UTI Asset Management Company Ltd (Q3 FY26)
Core income (Sale of Services): ₹322 crore, up 5% YoY . Key concall takeaways from UTI Asset Management Company Ltd's Q3 FY26 earnings call — and how it ranks…
- Geojit Financial Services Ltd (Q3 FY26)
Q3 FY26 Revenue from Operations:** ₹160.11 Crores . Key concall takeaways from Geojit Financial Services Ltd's Q3 FY26 earnings call — and how it ranks against…
- Dam Capital Advisors Ltd (Q3 FY26)
Total income for Q3FY26: INR 69.9 Cr (Page 15) . Key concall takeaways from Dam Capital Advisors Ltd's Q3 FY26 earnings call — and how it ranks against sector…
Frequently Asked Questions
What were CARE Ratings Ltd Q3 FY26 results?
Q3 FY26 Standalone Revenue from Operations: Rs. Q3 FY26 Standalone: - EBITDA: Rs.
What is CARE Ratings Ltd share price analysis?
CARE Ratings Ltd currently shows a neutral. The stock trades at a P/E of 28.3 with a market cap of ₹5,026 Cr. Investors should review the full earnings analysis for detailed insights.
Is CARE Ratings Ltd planning capital expenditure?
The investor presentation does not explicitly mention any capex, capacity expansions, new plants, or projects, nor does it provide related amounts, status, or timelines.
Keep CARE Ratings Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.